Q2 2026 results exceeded revenue and adjusted EBITDA guidance, driven by strong execution and the Vitalware divestiture, which enabled full debt repayment and a focus on core technology. Guidance was updated to reflect the divestiture, with continued investment in transformation and margin pressure from migrations.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.